Genemarkers provides collaborative services that enhance the utilization of genomics for improving health care, pharmaceutical research and consumer products. We take pride in providing high quality data and customer service. Our strength lies in our flexibility and personalized approach, allowing Genemarkers to meet the unique needs of each of our clients.
Pharmacogenomics (PGX) testing is rapidly emerging in clinical practice as medicine moves from a one-size-fits-all model to a precision medicine approach. PGX testing is used to:
Genemarkers CEO Dr. Anna Langerveld recently joined the Advisory Board for the Master of Science in Pharmacogenomics Program at Manchester University. Manchester is the first university to offer a one-year Master of Science in Pharmacogenomics, [...]
Genemarkers is pleased to welcome Elaina Breznau, PhD to its scientific team. Elaina earned her PhD in Cell & Molecular Biology from the University of Michigan, with expertise in epithelial cell function. She is an [...]
Genemarkers added Mindy S. Goldstein, PhD to its team of scientific consultants. Her 25-plus years of experience in personal care and nutraceutical product development will be an asset to the company’s customer base, it said. [...]
A private donor has awarded Western Michigan University Homer Stryker M.D. School of Medicine a nearly $1.5 million grant to conduct a clinical study evaluating the clinical utility of pharmacogenomic testing in Kalamazoo’s community mental [...]